Tag Archives: Nasopharyngeal carcinoma

Docetaxel (Taxotere) is Effective in Heavily Pretreated Nasopharyngeal Carcinoma Patients

It is well-established that nasopharyngeal carcinoma (NPC) is a chemo-responsive disease.  Despite improved outcome with chemo-radiation (platimum-based chemotherapy with radiation), treatment failure continue to be a problem in patients with locally advanced Stage III/IV disease.  Now, a new study published … Continue reading

Posted in Cancer, Nasopharyngeal Cancer | Tagged , , , , , , , | Comments Off on Docetaxel (Taxotere) is Effective in Heavily Pretreated Nasopharyngeal Carcinoma Patients